Send us Feedback

Eli Lilly and Company (LLY)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

LLY » Topics » (a)2. Financial Statement Schedules

This excerpt taken from the LLY 10-K filed Feb 22, 2010.
(a)2.  Financial Statement Schedules
 
The consolidated financial statement schedules of the Company and its subsidiaries have been omitted because they are not required, are inapplicable, or are adequately explained in the financial statements.
 
Financial statements of interests of 50 percent or less, which are accounted for by the equity method, have been omitted because they do not, considered in the aggregate as a single subsidiary, constitute a significant subsidiary.
 
These excerpts taken from the LLY 10-K filed Feb 27, 2009.
(a)2.     Financial Statement Schedules
 
The consolidated financial statement schedules of the Company and its subsidiaries have been omitted because they are not required, are inapplicable, or are adequately explained in the financial statements.
 
Financial statements of interests of 50 percent or less, which are accounted for by the equity method, have been omitted because they do not, considered in the aggregate as a single subsidiary, constitute a significant subsidiary.
 
(a)3.     Exhibits
 
         
  2     Agreement and Plan of Merger dated October 6, 2008, among Eli Lilly and Company, Alaska Acquisition Corporation and ImClone Systems Incorporated
  3 .1   Amended Articles of Incorporation
  3 .2   By-laws, as amended
  4 .1   Form of Indenture with respect to Debt Securities dated as of February 1, 1991, between Eli Lilly and Company and Citibank, N.A., as Trustee


-91-

 

         
  4 .2   Agreement dated September 13, 2007 appointing Deutsche Bank Trust Company Americas as Successor Trustee under the Indenture listed above
  4 .3   Form of Standard Multiple-Series Indenture Provisions dated, and filed with the Securities and Exchange Commission on, February 1, 1991
  4 .4   Form of Indenture dated March 10, 1998, among The Lilly Savings Plan Master Trust Fund C, as issuer; Eli Lilly and Company, as guarantor; and The Chase Manhattan Bank, as Trustee, relating to ESOP Amortizing Debentures due 20171
  4 .5   Form of Fiscal Agency Agreement dated May 30, 2001, between Eli Lilly and Company and Citibank, N.A., Fiscal Agent, relating to Resetable Floating Rate Debt Security due 20371
  4 .6   Form of Resetable Floating Rate Debt Security due 20371
  10 .1   1998 Lilly Stock Plan, as amended2
  10 .2   2002 Lilly Stock Plan, as amended2
  10 .3   Form of Performance Award under 2002 Lilly Stock Plan2
  10 .4   Form of two-year Performance Award under 2002 Lilly Stock Plan2
  10 .5   Form of Shareholder Value Award under 2002 Lilly Stock Plan2
  10 .6   The Lilly Deferred Compensation Plan, as amended2
  10 .7   The Lilly Directors’ Deferral Plan, as amended2
  10 .8   The Eli Lilly and Company Bonus Plan, as amended2
  10 .9   2007 Change in Control Severance Pay Plan for Select Employees, as amended effective January 1, 20092
  10 .10   2007 Change in Control Severance Pay Plan for Select Employees, as amended effective October 20, 20102
  10 .11   Letter agreement between the company and Charles E. Golden concerning retirement benefits2
  10 .12   Letter agreement between the company and Steven M. Paul, M.D. concerning retirement benefits2
  10 .13   Arrangement regarding retirement benefits for Robert A. Armitage2
  10 .14   Time Sharing Agreement between the company and Sidney Taurel for use of corporate aircraft
  10 .15   Guilty Plea Agreement in The United States District Court for the Eastern District of Pennsylvania, United States of America v. Eli Lilly and Company
  10 .16   Settlement Agreement among the company and the United States of America, acting through the United States Department of Justice, Civil Division, and the United States Attorney’s Office of the Eastern District of Pennsylvania, the Office of the Inspector General of the Department of Health and Human Services, TRICARE Management Activity, and the United States Office of Personnel Management, and certain individual relators
  10 .17   Corporate Integrity Agreement between the company and the Office of Inspector General of the Department of Health and Human Services
  12     Statement re: Computation of Ratio of Earnings (Loss) to Fixed Charges
  21     List of Subsidiaries
  23     Consent of Independent Registered Public Accounting Firm
  31 .1   Rule 13a-14(a) Certification of John C. Lechleiter, Ph.D., Chairman of the Board, President and Chief Executive Officer
  31 .2   Rule 13a-14(a) Certification of Derica W. Rice, Senior Vice President and Chief Financial Officer
  32     Section 1350 Certification
 
 
1 This exhibit is not filed with this report. Copies will be furnished to the Securities and Exchange Commission upon request.
2 Indicates management contract or compensatory plan.

-92-

 

(a)2.     Financial
Statement Schedules


 



The consolidated financial statement schedules of the Company
and its subsidiaries have been omitted because they are not
required, are inapplicable, or are adequately explained in the
financial statements.


 



Financial statements of interests of 50 percent or less,
which are accounted for by the equity method, have been omitted
because they do not, considered in the aggregate as a single
subsidiary, constitute a significant subsidiary.


 



(a)3.     Exhibits


 








































         

 

2

 

 

Agreement and Plan of Merger dated October 6, 2008, among
Eli Lilly and Company, Alaska Acquisition Corporation and
ImClone Systems Incorporated

 

3

.1

 

Amended Articles of Incorporation

 

3

.2

 

By-laws, as amended

 

4

.1

 

Form of Indenture with respect to Debt Securities dated as of
February 1, 1991, between Eli Lilly and Company and
Citibank, N.A., as Trustee





-91-




 



















































































































































































































         

 

4

.2

 

Agreement dated September 13, 2007 appointing Deutsche Bank
Trust Company Americas as Successor Trustee under the Indenture
listed above

 

4

.3

 

Form of Standard Multiple-Series Indenture Provisions
dated, and filed with the Securities and Exchange Commission on,
February 1, 1991

 

4

.4

 

Form of Indenture dated March 10, 1998, among The Lilly
Savings Plan Master Trust Fund C, as issuer; Eli Lilly
and Company, as guarantor; and The Chase Manhattan Bank, as
Trustee, relating to ESOP Amortizing Debentures due
20171


 

4

.5

 

Form of Fiscal Agency Agreement dated May 30, 2001, between
Eli Lilly and Company and Citibank, N.A., Fiscal Agent, relating
to Resetable Floating Rate Debt Security due
20371


 

4

.6

 

Form of Resetable Floating Rate Debt Security due
20371


 

10

.1

 

1998 Lilly Stock Plan, as
amended2


 

10

.2

 

2002 Lilly Stock Plan, as
amended2


 

10

.3

 

Form of Performance Award under 2002 Lilly Stock
Plan2


 

10

.4

 

Form of two-year Performance Award under 2002 Lilly Stock
Plan2


 

10

.5

 

Form of Shareholder Value Award under 2002 Lilly Stock
Plan2


 

10

.6

 

The Lilly Deferred Compensation Plan, as
amended2


 

10

.7

 

The Lilly Directors’ Deferral Plan, as
amended2


 

10

.8

 

The Eli Lilly and Company Bonus Plan, as
amended2


 

10

.9

 

2007 Change in Control Severance Pay Plan for Select Employees,
as amended effective January 1,
20092


 

10

.10

 

2007 Change in Control Severance Pay Plan for Select Employees,
as amended effective October 20,
20102


 

10

.11

 

Letter agreement between the company and Charles E. Golden
concerning retirement
benefits2


 

10

.12

 

Letter agreement between the company and Steven M.
Paul, M.D. concerning retirement
benefits2


 

10

.13

 

Arrangement regarding retirement benefits for Robert A.
Armitage2


 

10

.14

 

Time Sharing Agreement between the company and Sidney Taurel for
use of corporate aircraft

 

10

.15

 

Guilty Plea Agreement in The United States District Court for
the Eastern District of Pennsylvania, United States of
America v. Eli Lilly and Company

 

10

.16

 

Settlement Agreement among the company and the United States of
America, acting through the United States Department of Justice,
Civil Division, and the United States Attorney’s Office of
the Eastern District of Pennsylvania, the Office of the
Inspector General of the Department of Health and Human
Services, TRICARE Management Activity, and the United States
Office of Personnel Management, and certain individual relators

 

10

.17

 

Corporate Integrity Agreement between the company and the Office
of Inspector General of the Department of Health and Human
Services

 

12

 

 

Statement re: Computation of Ratio of Earnings (Loss) to Fixed
Charges

 

21

 

 

List of Subsidiaries

 

23

 

 

Consent of Independent Registered Public Accounting Firm

 

31

.1

 

Rule 13a-14(a) Certification of John C. Lechleiter, Ph.D.,
Chairman of the Board, President and Chief Executive Officer

 

31

.2

 

Rule 13a-14(a) Certification of Derica W. Rice, Senior Vice
President and Chief Financial Officer

 

32

 

 

Section 1350 Certification





 
 


1 This

exhibit is not filed with this report. Copies will be furnished
to the Securities and Exchange Commission upon request.



2 Indicates

management contract or compensatory plan.



-92-




 







These excerpts taken from the LLY 10-K filed Oct 21, 2008.
(a)2.     Financial Statement Schedules
 
The consolidated financial statement schedules of the Company and its subsidiaries have been omitted because they are not required, are inapplicable, or are adequately explained in the financial statements.
 
Financial statements of interests of 50 percent or less, which are accounted for by the equity method, have been omitted because they do not, considered in the aggregate as a single subsidiary, constitute a significant subsidiary.
 
(a)2.     Financial
Statement Schedules


 



The consolidated financial statement schedules of the Company
and its subsidiaries have been omitted because they are not
required, are inapplicable, or are adequately explained in the
financial statements.


 



Financial statements of interests of 50 percent or less,
which are accounted for by the equity method, have been omitted
because they do not, considered in the aggregate as a single
subsidiary, constitute a significant subsidiary.


 




These excerpts taken from the LLY 10-K filed Feb 29, 2008.
(a)2.     Financial Statement Schedules
 
The consolidated financial statement schedules of the Company and its subsidiaries have been omitted because they are not required, are inapplicable, or are adequately explained in the financial statements.
 
Financial statements of interests of 50 percent or less, which are accounted for by the equity method, have been omitted because they do not, considered in the aggregate as a single subsidiary, constitute a significant subsidiary.
 
(a)2.     Financial
Statement Schedules


 



The consolidated financial statement schedules of the Company
and its subsidiaries have been omitted because they are not
required, are inapplicable, or are adequately explained in the
financial statements.


 



Financial statements of interests of 50 percent or less,
which are accounted for by the equity method, have been omitted
because they do not, considered in the aggregate as a single
subsidiary, constitute a significant subsidiary.


 




This excerpt taken from the LLY 10-K filed Feb 28, 2007.
(a)2.     Financial Statement Schedules
 
The consolidated financial statement schedules of the Company and its subsidiaries have been omitted because they are not required, are inapplicable, or are adequately explained in the financial statements.
 
Financial statements of interests of 50 percent or less, which are accounted for by the equity method, have been omitted because they do not, considered in the aggregate as a single subsidiary, constitute a significant subsidiary.
 
(a)3.      Exhibits
 
         
  3 .1   Amended Articles of Incorporation
  3 .2   By-laws, as amended
  4 .1   Rights Agreement dated as of July 20, 1998, between Eli Lilly and Company and Norwest Bank Minnesota, N.A., as successor Rights Agent
  4 .2   Amendment No. 1 to Rights Agreement dated as of May 27, 2003, between Eli Lilly and Company and Wells Fargo Bank Minnesota, N.A., as successor Rights Agent
  4 .3   Form of Indenture with respect to Debt Securities dated as of February 1, 1991, between Eli Lilly and Company and Citibank, N.A., as Trustee
  4 .4   Form of Standard Multiple-Series Indenture Provisions dated, and filed with the Securities and Exchange Commission on, February 1, 1991
  4 .5   Form of Indenture dated March 10, 1998, among The Lilly Savings Plan Master Trust Fund C, as issuer; Eli Lilly and Company, as guarantor; and The Chase Manhattan Bank, as Trustee, relating to ESOP Amortizing Debentures due 20171
  4 .6   Form of Fiscal Agency Agreement dated May 30, 2001, between Eli Lilly and Company and Citibank, N.A., Fiscal Agent, relating to Resetable Floating Rate Debt Security due May 15, 20371
  4 .7   Form of Resetable Floating Rate Debt Security due May 15, 20371
  4 .8   Form of Indenture, dated as of August 9, 2005, by and among Eli Lilly and Company, Eli Lilly Services, Inc., and Citibank, N.A., as trustee1
  4 .9   Form of Floating Rate Note of Eli Lilly Services, Inc. due September 12, 20081
 
 
1 This exhibit is not filed with this report. Copies will be furnished to the Securities and Exchange Commission upon request.


-78-

 

         
  10 .1   1994 Lilly Stock Plan, as amended2
  10 .2   1998 Lilly Stock Plan, as amended2
  10 .3   2002 Lilly Stock Plan, as amended2
  10 .4   Lilly GlobalShares Stock Plan, as amended2
  10 .5   The Lilly Deferred Compensation Plan, as amended2
  10 .6   The Lilly Directors’ Deferral Plan, as amended2
  10 .7   The Eli Lilly and Company Bonus Plan, as amended2
  10 .8   Eli Lilly and Company Change in Control Severance Pay Plan for Select Employees, as amended2
  10 .9   2007 Change in Control Severance Pay Plan for Select Employees, as amended2
  10 .10   Letter agreement between the company and Charles E. Golden concerning retirement benefits2
  10 .11   Letter agreement between the company and Steven M. Paul, M.D. concerning retirement benefits2
  10 .12   Arrangement regarding retirement benefits for Robert A. Armitage2
  10 .13   Time Sharing Agreement between the company and Sidney Taurel for use of corporate aircraft
  10 .14   Master Settlement Agreement regarding Zyprexa product liability claims
  10 .15   Agreement and Plan of Merger by and among the Company, Tour Merger Sub, Inc. and ICOS Corporation
  10 .16   Amendment No. 1 to the above-listed Agreement and Plan of Merger
  12 .   Statement re: Computation of Ratio of Earnings to Fixed Charges
  21 .   List of Subsidiaries
  23 .   Consent of Independent Registered Public Accounting Firm
  31 .1   Rule 13a-14(a) Certification of Sidney Taurel, Chairman of the Board and Chief Executive Officer
  31 .2   Rule 13a-14(a) Certification of Derica W. Rice, Senior Vice President and Chief Financial Officer
  32 .   Section 1350 Certification
 
 
2 Indicates management contract or compensatory plan.

-79-

 

EXCERPTS ON THIS PAGE:

10-K
Feb 22, 2010
10-K (2 sections)
Feb 27, 2009
10-K (2 sections)
Oct 21, 2008
10-K (2 sections)
Feb 29, 2008
10-K
Feb 28, 2007

RELATED TOPICS for LLY:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki